1. Alépée, N., Tornier, C., Robert, C., Amsellem, C., Roux, M.H., Doucet, O., Pachot, J., Méloni, M., de Brugerolle de Fraissinette, A., 2010. A catch-up validation study on reconstructed human epidermis (SkinEthic RHE) for full replacement of the Draize skin irritation test. Toxicol. In Vitro. 24(1), 257–266. https://doi.org/10.1016/j.tiv.2009.08.024.
2. Arena, M., van der Linden, S., 2021. Annex A - Use of the XETA in the assessment strategy of the ECHA/EFSA. Annex to Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009. EFSA J. 2018;16(6), 5311. https://efsa.onlinelibrary.wiley.com/action/downloadSupplement?doi=10.2903%2Fj.efsa.2018.5311&file=efs25311-sup-0002-Annex.pdf.
3. ASTM, 2019. American Society for Testing and Materials Standard E1439-12(2019). Standard guide for conducting the frog embryo teratogenesis assay-Xenopus (FETAX). ASTM-Volume 11.06. https://doi.org/10.1520/E1439-12R19.
4. Simulated developmental and reproductive impacts on amphibian populations and implications for assessing long-term effects;Awkerman;Environ. Toxicol. Chem.,2018
5. Science based guidance for the assessment of endocrine disrupting properties of chemicals;Bars;Regul. Toxicol. Pharm.,2011